Allen Moseley - Streamline Health Independent Director
| STRM Stock | USD 0.34 0.01 3.03% |
Director
Mr. Allen S. Moseley is Independent Director of Streamline Health Solutions, Inc. He has served as a General Partner at NoroMoseley Partners since 1998 and leads the firm healthcare practice focused primarily in healthcare information technology, healthcare services, and medical devices. He currently represents NoroMoseley on the boards of various healthcare vendors. Prior to joining NoroMoseley, Mr. Moseley was in the corporate finance group at The RobinsonHumphrey Company, an investment banking firm previously owned by Citigroup and now part of SunTrust Banks, Inc. Mr. Moseley worked extensively in the healthcare and business services industries, advising on a number of initial public offerings, mergers and acquisitions, and private placements. He also was involved in RH Capital Partners, the private equity investment arm of the firm. Previously, he held investment banking positions with Bowles Hollowell Conner Company and Merrill Lynch Co. Mr. Moseley currently serves on the Board of Trustees of the Georgia Research Alliance and the Board of Directors of the Technology Association of Georgia. He was recently Chairman of Venture Atlanta and Chairman of the Technology Association of Georgia since 2012.
| Age | 46 |
| Tenure | 12 years |
| Professional Marks | MBA |
| Address | 2400 Old Milton Pkwy, Alpharetta, GA, United States, 30009 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1144) % which means that it has lost $0.1144 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7237) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to -0.7. In addition to that, Return On Capital Employed is likely to grow to -0.26. At this time, Streamline Health's Total Assets are very stable compared to the past year. As of the 25th of April 2024, Non Current Assets Total is likely to grow to about 55 M, while Total Current Assets are likely to drop about 12.8 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Frank Medici | HealthEquity | 53 | |
| Manu Rana | HealthEquity | 45 | |
| P Shastri | National Research Corp | 65 | |
| Frank Corvino | HealthEquity | 68 | |
| JoAnn Martin | National Research Corp | 63 | |
| Martiny Harris | HealthStream | 59 | |
| Thompson Dent | HealthStream | 68 | |
| Harald Arnet | National Research Corp | N/A | |
| Michael Leavitt | HealthEquity | 66 | |
| Martin Harris | HealthStream | 61 | |
| Linda Rebrovick | HealthStream | 62 | |
| Jeffrey McLaren | HealthStream | 51 | |
| Gayle Wellborn | HealthEquity | 56 | |
| Kjersti Kanne | National Research Corp | N/A | |
| Michael Shmerling | HealthStream | 62 | |
| Brita Eilertsen | National Research Corp | 53 | |
| Diane Patrick | Agiliti | 69 | |
| Savita Acharya | National Research Corp | 41 | |
| John Nunnelly | National Research Corp | 65 | |
| Ian Sacks | HealthEquity | 47 | |
| Donald Berwick | National Research Corp | 71 | |
Management Performance
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Jawad Shaikh, Chief Officer | ||
| Wyche Green, Director | ||
| David Sides, CEO and President and Director | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Lois Rickard, Chief People Officer and Sr. VP | ||
| Luciana Mullen, Principal Accounting Officer | ||
| Amy Sebero, Chief Officer | ||
| Shaun Priest, Senior Vice President and Chief Growth Officer | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Jack Kennedy, Chief Legal Counsel and Sr. VP of Admin. | ||
| Lance Seach, Senior Development | ||
| Kenan Lucas, Director | ||
| Nicholas Meeks, CFO, Senior Vice President | ||
| Michael Valentine, Independent Director | ||
| Allen Moseley, Independent Director | ||
| Randolph Salisbury, Chief Marketing Officer and Sr. VP | ||
| Jonathan Phillips, Independent Chairman of the Board | ||
| Benjamin Stilwill, Chief Officer | ||
| William Garvis, COO, Senior Vice President | ||
| Michael Kaplan, Independent Director | ||
| Judith Starkey, Director | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.81) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | (1.85 M) | ||||
| Shares Outstanding | 59.09 M | ||||
| Shares Owned By Insiders | 28.21 % | ||||
| Shares Owned By Institutions | 31.84 % | ||||
| Number Of Shares Shorted | 58.15 K | ||||
| Price To Earning | 321.67 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Streamline Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Streamline Health's short interest history, or implied volatility extrapolated from Streamline Health options trading.
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.